Joseph K. Belanoff

Chief Executive Officer at Corcept Therapeutics Incorporated

Sits on 1 board. Last updated September 28, 2026

Time on boards

Boards served
1
Current seats
1
Board service
4 years
Director since
2023

4 years of board service in total across 1 board, counting each seat separately. Longest: Corcept Therapeutics Incorporated, 3 years.

Corcept Therapeutics Incorporated Director · Chief Executive Officer
3 years · Since 2023

Chief executive roles

Corcept Therapeutics Incorporated · Chief Executive Officer
Dates unknown

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Jun 1, 2026 Corcept Therapeutics Incorporated Open-market sale −12,837 $69.74 $895,252
May 29, 2026 Corcept Therapeutics Incorporated Gift −300,000 — —
May 29, 2026 Corcept Therapeutics Incorporated Gift +150,000 — —
May 29, 2026 Corcept Therapeutics Incorporated Gift +150,000 — —
May 1, 2026 Corcept Therapeutics Incorporated Open-market sale −40,000 $50.10 $2,004,000
Mar 25, 2026 Corcept Therapeutics Incorporated Open-market sale −26,198 $50.07 $1,311,734
Dec 24, 2025 Corcept Therapeutics Incorporated Option exercise +550,000 $3.88 $2,134,000
Dec 24, 2025 Corcept Therapeutics Incorporated Shares withheld for tax −306,846 $83.59 $25,649,257
Dec 24, 2025 Corcept Therapeutics Incorporated Gift −243,154 — —
Dec 24, 2025 Corcept Therapeutics Incorporated Other +243,154 — —
Dec 1, 2025 Corcept Therapeutics Incorporated Open-market sale −40,000 $79.77 $3,190,800
Nov 5, 2025 Corcept Therapeutics Incorporated Open-market sale −14,355 $74.20 $1,065,141
Nov 5, 2025 Corcept Therapeutics Incorporated Open-market sale −10,837 $75.14 $814,292
Nov 5, 2025 Corcept Therapeutics Incorporated Open-market sale −3,590 $75.98 $272,768
Nov 3, 2025 Corcept Therapeutics Incorporated Open-market sale −11,218 $74.08 $831,029

Questions about Joseph K. Belanoff

What boards is Joseph K. Belanoff on?

Joseph K. Belanoff sits on the board of Corcept Therapeutics Incorporated.

What company is Joseph K. Belanoff the CEO of?

Joseph K. Belanoff is Chief Executive Officer of Corcept Therapeutics Incorporated.

How long has Joseph K. Belanoff served on boards?

Our records show at least 4 years of board service across 1 board, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.